1 GLOCON.018/2020 May 15th, 2020 Subject Management’s discussion and analysis for 1st quarter of 2020 Attn. The President The Stock Exchange of Thailand Management’s analysis Consolidated Financial
Stock Exchange of Thailand With respect to the financial information for the 2nd quarter ended 30 June 2020, as submitted by the Company, which has been audited by the external auditor, considered by the
, 2020 Subject Management’ Discussion and Analysis for the 1st Quarter in 2020 To Directors & Managers The Stock Exchange of Thailand Inter Pharma Public Company Limited (“the Company”) hereby submitting
29 October 2019 At: ACC/HO 023/19 Re: Management Discussion and Analysis for the Quarter of 3/2019 To: President The Stock Exchange of Thailand In the third quarter of 2019, there were concern on the
Operating Results of the Company in Q2/2019 Q2/18 Q2/19 1H/18 1H/19 Change +/(-) (THB million) YoY 1H Operating Revenue 206 312 51% 405 599 48% Gross Profit 138 201 46% 273 389 42% EBITDA 49 95 94% 99 186 88
value will be realized in profit and loss statement in such period. In 1Q2020, the significant change in fair value of derivatives the Company has was from the conversion option embedded in convertible
– Translation – No. FSS.CS 20/2561 April 27, 2018 Subject: The Disposition of the Remaining Investment in Joint Venture Company To: President The Stock Exchange of Thailand As Finansia Syrus
the Stock Exchange of Thailand The Company would like to clarify the net profit for the 9-month periods of the year ending on 30th September 2018 had decreased more than 20% comparing to the same period
M.D. 219/2019 November 12, 2019 Subject : Disclosure of the information connected transaction To : President of the Stock of Exchange of Thailand Kang Yong Electric Public Company Limited hereby